소아청소년 양극성장애 환자에서 리튬 치료에 따른 소변 오스몰랄농도의 변화
Changes in Urine Osmolal Concentration with Lithium Treatment in Children and Youth with Bipolar Disorder
0
조회
0
다운로드
0
인용
0
참고문헌
초록
Objectives Bipolar disorder has a high rate of recurrence, which can cause problems such as declines in cognitive and social functions. Lithium is the primary medication for preventing recurrence, but the medication compliance is poor owing to side effects that include diarrhea, tremor, polyuria, polydipsia, diabetes insipidus, increased creatinine level, and weight gain. Polyuria and polydipsia also cause voluntary discontinuation of the medication. However, no domestic and international studies have evaluated the direct correlation between lithium therapy and polydipsia in pediatric patients. Therefore, we assessed this relationship by evaluating urine osmolality changes after lithium administration in pediatric patients. Methods This study focused on patients admitted to the Department of Psychiatry, Pusan National University Yangsan Hospital. Patients had bipolar disorder types I or II and other specified bipolar disorders based on the DSM-5, criteria at discharge from December 1, 2018, to April 31, 2020. Urine osmolarity changes from admission to discharge in the patients who used lithium for the first time after admission were reviewed. Results For 47 patients, the change in osmolality was statistically significant (mean, 203.32± 280.68; p<0.001) and significantly higher in those aged <14 years than in those aged ≥14 years (p=0.038). Antipsychotic use and sex-related differences did not affect urine osmolality. Conclusion The first-time users of lithium had significantly reduced urine osmolality at discharge. Considering the lithium effect on the kidneys, a prospective study to identify the relationship between lithium use and polydipsia is necessary.
Abstract
Objectives Bipolar disorder has a high rate of recurrence, which can cause problems such as declines in cognitive and social functions. Lithium is the primary medication for preventing recurrence, but the medication compliance is poor owing to side effects that include diarrhea, tremor, polyuria, polydipsia, diabetes insipidus, increased creatinine level, and weight gain. Polyuria and polydipsia also cause voluntary discontinuation of the medication. However, no domestic and international studies have evaluated the direct correlation between lithium therapy and polydipsia in pediatric patients. Therefore, we assessed this relationship by evaluating urine osmolality changes after lithium administration in pediatric patients. Methods This study focused on patients admitted to the Department of Psychiatry, Pusan National University Yangsan Hospital. Patients had bipolar disorder types I or II and other specified bipolar disorders based on the DSM-5, criteria at discharge from December 1, 2018, to April 31, 2020. Urine osmolarity changes from admission to discharge in the patients who used lithium for the first time after admission were reviewed. Results For 47 patients, the change in osmolality was statistically significant (mean, 203.32± 280.68; p<0.001) and significantly higher in those aged <14 years than in those aged ≥14 years (p=0.038). Antipsychotic use and sex-related differences did not affect urine osmolality. Conclusion The first-time users of lithium had significantly reduced urine osmolality at discharge. Considering the lithium effect on the kidneys, a prospective study to identify the relationship between lithium use and polydipsia is necessary.
참고문헌 (39)
- Merikangas KR, "Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication", Arch Gen Psychiatry, 64, pp.543~552 (2007)
- Gitlin MJ, "Relapse and impairment in bipolar disorder", Am J Psychiatry, 152, pp.1635~1640 (1995)
- Müller-Oerlinghausen B, "Bipolar disorder", Lancet, 359, pp.241~247 (2002)
- Martinez-Arán A, "Executive function in patients with remitted bipolar disorder and schizophrenia and its relationship with functional outcome", Psychother Psychosom, 71, pp.39~46 (2002)
- Krahn GL, "WHO world report on disability : a review", Disabil Health J, 4, pp.141~142 (2011)
- Cade JF, "Lithium salts in the treatment of psychotic excitement", Med J Aust, 2, pp.349~352 (1949)
- Geddes JR, "Longterm lithium therapy for bipolar disorder : systematic review and meta-analysis of randomized controlled trials", Am J Psychiatry, 161, pp.217~222 (2004)
- Vieta E, "Psychiatrists’ perceptions of potential reasons for non-and partial adherence to medication : results of a survey in bipolar disorder from eight European countries", J Affect Disord, 143, pp.125~130 (2012)
- Suppes T, "Risk of recurrence following discontinuation of lithium treatment in bipolar disorder", Arch Gen Psychiatry, 48, pp.1082~1088 (1991)
- Öhlund L, "Reasons for lithium discontinuation in men and women with bipolar disorder : a retrospective cohort study", BMC psychiatry, 18, pp.37~ (2018)
- Gitlin M, "Lithium side effects and toxicity : prevalence and management strategies", Int J Bipolar Disord, 4, pp.27~ (2016)
- McKnight RF, "Lithium toxicity profile : a systematic review and meta-analysis", Lancet, 379, pp.721~728 (2012)
- Bendz H, "Kidney damage in long-term lithium patients : a cross-sectional study of patients with 15 years or more on lithium", Nephrol Dial Transplant, 9, pp.1250~1254 (1994)
- Bendz H, "Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithium-withdrawal study", Nephrol Dial Transplant, 11, pp.457~460 (1996)
- van Melick EJ, "Renal effects of long-term lithium therapy in the elderly : a cross-sectional study", Int J Geriatr Psychiatry, 23, pp.685~692 (2008)
- Gitlin M, "Lithium and the kidney : an updated review", Drug Saf, 20, pp.231~243 (1999)
- Bendz H, "A historical cohort study of kidney damage in long-term lithium patients : continued surveillance needed", Eur Psychiatry, 16, pp.199~206 (2001)
- Pradhan BK, "Distress due to lithium-induced polyuria : exploratory study", Psychiatry Clin Neurosci, 65, pp.386~388 (2011)
- Rej S, "The McGill geriatric lithium-induced diabetes insipidus clinical study(McGLIDICS)", Can J Psychiatry, 59, pp.327~334 (2014)
- Azab AN, "Lithium nephrotoxicity", Int J Bipolar Disord, 3, pp.13~ (2015)
- Garofeanu CG, "Causes of reversible nephrogenic diabetes insipidus : a systematic review", Am J Kidney Dis, 45, pp.626~637 (2005)
- Grandjean EM, "Lithium : updated human knowledge using an evidence-based approach : part III : clinical safety", CNS Drugs, 23, pp.397~418 (2009)
- Christ-Crain M, "Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria–polydipsia and hyponatremia", Best Pract Res Clin Endocrinol Metab, 30, pp.235~247 (2016)
- Siegel AJ, "Is urine concentration a reliable biomarker to guide vaptan usage in psychiatric patients with symptomatic hyponatremia", Psychiatry Res, 226, pp.403~404 (2015)
- Nigro N, "Polyuria-polydipsia syndrome : a diagnostic challenge", Intern Med J, 48, pp.244~253 (2018)
- Markowitz GS, "Lithium nephrotoxicity : a progressive combined glomerular and tubulointerstitial nephropathy", J Am Soc Nephrol, 11, pp.1439~1448 (2000)
- Cox M, "Lithium and water metabolism", Am J Med, 59, pp.153~157 (1975)
- Trepiccione F, "Lithium-induced nephrogenic diabetes insipidus : new clinical and experimental findings", J Nephrol, 16, pp.S43~S48 (2010)
- Rej S, "Chronic kidney disease in lithium-treated older adults: a review of epidemiology, mechanisms, and implications for the treatment of late-life mood disorders", Drugs Aging, 32, pp.31~42 (2015)
- Boton R, "Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy", Am J Kidney Dis, 10, pp.329~345 (1987)
- Kearns GL, "Developmental pharmacology--drug disposition, action, and therapy in infants and children", N Engl J Med, 349, pp.1157~1167 (2003)
- Bhimma R, "Kidney disease in children and adolescents with perinatal HIV-1 infection", J Int AIDS Soc, 16, pp.18596~ (2013)
- Pazhayattil GS, "Drug-induced impairment of renal function", Int J Nephrol Renovasc Dis, 7, pp.457~468 (2014)
- Treszl A, "Interleukin genetic variants and the risk of renal failure in infants with infection", Pediatr Nephrol, 17, pp.713~717 (2002)
- Pettit JW, "Pilot sample of very early onset bipolar disorder in a military population moderates the association of negative life events and non-fatal suicide attempt", Bipolar Disord, 8, pp.475~484 (2006)
- Propper L, "Early-onset and very-early-onset bipolar disorder : distinct or similar clinical conditions", Bipolar Disord, 17, pp.814~820 (2015)
- Perlis RH, "Long-term implications of early onset in bipolar disorder : data from the first 1000 participants in the systematic treatment enhancement program for bipolar disorder(STEP-BD)", Biol Psychiatry, 55, pp.875~881 (2004)
- Atsariyasing W, "A systematic review of the ability of urine concentration to distinguish antipsychotic-from psychosis-induced hyponatremia", Psychiatry Res, 217, pp.129~133 (2014)
- Rybakowski JK, "Screening for the markers of kidney damage in men and women on long-term lithium treatment", Med Sci Monit (2012)